Eculizumab – What’s the point?
Eculizumab is a monoclonal antibody, marketed as Soliris, that improves the inflammatory response and decreases the body’s ability to attack its blood cells, being primarily indicated to combat a rare disease called nocturnal paroxystic hemoglobinuria. The drug Soliris is indicated for the treatment of a blood disorder called paroxysmal nocturnal hemoglobinuria; a disease of the […]